Exchange: NASDAQ·Updated 04:10 PM EST

About DSGN

About

Design Therapeutics, Inc. operates as a biotechnology company that develops therapies for serious degenerative disorders. It is created to design, develop and commercialize a novel class of small molecule therapeutic candidates (GeneTACs) designed to directly address the underlying basis of genetic disease. The company was founded by Pratik Shah and Aseem Z. Ansari on December 18, 2017 and is headquartered in Carlsbad, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
124

Frequently Asked Questions

Advertisement|Remove ads.